These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24085298)

  • 1. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration.
    Franceschetti T; Kessler CB; Lee SK; Delany AM
    J Biol Chem; 2013 Nov; 288(46):33347-60. PubMed ID: 24085298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mmu-miR-185 regulates osteoclasts differentiation and migration by targeting Btk.
    He D; Jiao Y; Xu J; Luo J; Cui Y; Han X; Zhao H
    J Gene Med; 2024 May; 26(5):e3687. PubMed ID: 38690623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathway analysis of microRNA expression profile during murine osteoclastogenesis.
    Franceschetti T; Dole NS; Kessler CB; Lee SK; Delany AM
    PLoS One; 2014; 9(9):e107262. PubMed ID: 25222202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice.
    Shin B; Hrdlicka HC; Delany AM; Lee SK
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34192317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.
    Rossi M; Pitari MR; Amodio N; Di Martino MT; Conforti F; Leone E; Botta C; Paolino FM; Del Giudice T; Iuliano E; Caraglia M; Ferrarini M; Giordano A; Tagliaferri P; Tassone P
    J Cell Physiol; 2013 Jul; 228(7):1506-15. PubMed ID: 23254643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
    Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
    Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
    Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
    Wu SH; Zhong ZM; Chen JT
    Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-223 is a key factor in osteoclast differentiation.
    Sugatani T; Hruska KA
    J Cell Biochem; 2007 Jul; 101(4):996-9. PubMed ID: 17471500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-340 inhibits osteoclast differentiation via repression of MITF.
    Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liver X receptor promotes macrophage differentiation and suppresses osteoclast formation in mouse RAW264.7 promyelocytic leukemia cells exposed to bacterial lipopolysaccharide.
    Robertson Remen KM; Gustafsson JÅ; Andersson G
    Biochem Biophys Res Commun; 2013 Jan; 430(1):375-80. PubMed ID: 23159616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
    Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
    J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.
    Kogawa M; Hisatake K; Atkins GJ; Findlay DM; Enoki Y; Sato T; Gray PC; Kanesaki-Yatsuka Y; Anderson PH; Wada S; Kato N; Fukuda A; Katayama S; Tsujimoto M; Yoda T; Suda T; Okazaki Y; Matsumoto M
    J Biol Chem; 2013 Oct; 288(43):31299-312. PubMed ID: 23990468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afamin stimulates osteoclastogenesis and bone resorption via Gi-coupled receptor and Ca2+/calmodulin-dependent protein kinase (CaMK) pathways.
    Kim BJ; Lee YS; Lee SY; Park SY; Dieplinger H; Yea K; Lee SH; Koh JM; Kim GS
    J Endocrinol Invest; 2013 Nov; 36(10):876-82. PubMed ID: 23698732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
    Granholm S; Lundberg P; Lerner UH
    J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.